Lobbying Law Should Not Hinder Science Advocacy, Observers Say

Advocacy, Observers Say conveying benefits of research. LET'S LOBBY: William Wells calls lobbying "perfectly legitimate" and urges scientists "to be at the table". Science lobbyists maintain that a new federal lobbying-reform law will not impede their advocacy efforts in Washington, D.C. What does worry them, however, is that many scientists still do not realize the importance of speaking to policy-makers and the public about the benefits of science and the importance of funding it. The Lobb

Written byThomas Durso
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Advocacy, Observers Say conveying benefits of research.

William Wells
LET'S LOBBY: William Wells calls lobbying "perfectly legitimate" and urges scientists "to be at the table".
Science lobbyists maintain that a new federal lobbying-reform law will not impede their advocacy efforts in Washington, D.C. What does worry them, however, is that many scientists still do not realize the importance of speaking to policy-makers and the public about the benefits of science and the importance of funding it.

The Lobbying Disclosure Act of 1995, passed overwhelmingly by the House and Senate and signed enthusiastically by President Clinton, took effect January 1. Among its requirements are that lobbyists register with Congress and report for whom they lobby and how much they receive for such activities (see story on page 9).

The measure marks the first reform of lobbying in 40 years. Supporters cheered its passage and claimed it would clean up lobbyist-lawmaker interaction, a relationship ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies